The test analyzes the levels of two proteins in the blood and has shown a link between these levels and patient outcomes. The pilot study showed that 98% of patients with low protein levels did not develop secondary breast cancer. The test could be ready for approval in two to three years.
Latest News
22:57
The Ministry of Defense announced that the Sadu Mechanical Plant produces NATO ammunition on two modern lines.
22:57
The Bucharest Stock Exchange closed Monday's session up.
22:42
The USA removes Syria from the list of state sponsors of terrorism.
22:29
The world's oceans have just reached the highest temperature ever recorded.
22:20
Netanyahu accuses Iran of an assassination attempt on one of his sons
See more news